TCT-210 Clinical Outcomes Following Resolute Zotarolimus-eluting Stent Implantation in Diabetic versus Non-Diabetic Patients Suitable for Percutaneous Coronary Revascularization: Insights From a Multicenter Italian Registry
2013
Diabetes mellitus remains a significant predictor of adverse clinical outcomes after percutaneous coronary intervention (PCI). Outcomes after 2nd generation drug-eluting stent (DES) implantation in diabetics remains ill-defined. Aim of this study was to compare the clinical outcomes of the Resolute
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI